Consensus recommendations on the management of hepatitis C in Australia's prisons
Introduction Prison settings represent the highest concentration of prevalent hepatitis C
cases in Australia due to the high rates of incarceration among people who inject drugs …
cases in Australia due to the high rates of incarceration among people who inject drugs …
FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study
R Catanzaro, A Aleo, M Sciuto, L Zanoli… - Clinical and …, 2021 - termedia.pl
Results Twenty-six patients (24.52%) had F4 fibrosis, 80 patients (75.48%) had non-F4
fibrosis (F0-F3). There was a statistically significant difference (p< 0.05) between non-F4 …
fibrosis (F0-F3). There was a statistically significant difference (p< 0.05) between non-F4 …
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically …
MB MacIsaac, B Whitton, J Anderson, S Cogger… - International Journal of …, 2024 - Elsevier
Background To achieve hepatitis C virus (HCV) elimination targets, simplified care engaging
people who inject drugs is required. We evaluated whether fingerstick HCV RNA point-of …
people who inject drugs is required. We evaluated whether fingerstick HCV RNA point-of …
Prevalence and risk factors of MASLD and liver fibrosis amongst the penitentiary population in catalonia: the PRISONAFLD study
J Rivera-Esteban, A Jiménez-Masip… - Journal of Clinical …, 2023 - mdpi.com
Background and Aims: The prevalence of chronic non-communicable diseases, particularly
metabolic syndrome (MetS), has increased among the prison population. Nevertheless, we …
metabolic syndrome (MetS), has increased among the prison population. Nevertheless, we …
An intervention to increase hepatitis C virus diagnosis and treatment uptake among people in custody in Iran
S Hariri, M Alavi, G Roshandel, Z Mohammadi… - International Journal of …, 2021 - Elsevier
Background Iran is among countries with high opioid agonist therapy (OAT) coverage in
prisons, which provides an infrastructure to increase feasibility of HCV programs. We aimed …
prisons, which provides an infrastructure to increase feasibility of HCV programs. We aimed …
An exploratory analysis of the competing effects of alcohol use and advanced hepatic fibrosis on serum HDL
AGL Vannier, A PeBenito, V Fomin, RT Chung… - Clinical and …, 2022 - Springer
While alcohol use has been shown to increase serum HDL, advanced liver disease
associates with decreased serum HDL. The combined influence of alcohol consumption and …
associates with decreased serum HDL. The combined influence of alcohol consumption and …